Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL2200023	RO7198574	HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB	Injection	Biological Products(2.2)	Import Drug Application	2022-03-07					view
JXSL2200024	RO7198574	HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB	Injection	Biological Products(2.2)	Import Drug Application	2022-03-07					view
JXSL2300039	RO7198574	HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB	Injection	Biological Products(2.2)	Import Drug Application	2023-02-22					view
JXSL2300038	RO7198574	HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB	Injection	Biological Products(2.2)	Import Drug Application	2023-02-22					view
JXSL1900025	RO7198574	HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB	Injection	Biological Products	Import Drug Application	2019-03-11	F.Hoffmann-La Roche Ltd	F Hoffmann-La Roche Ltd(Switzerland)	In Review	2019-03-08	view
JXSL1900024	RO7198574	HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB	Injection	Biological Products	Import Drug Application	2019-03-11	F.Hoffmann-La Roche Ltd	F Hoffmann-La Roche Ltd(Switzerland)	In Review	2019-03-08	view
JXSB2000038	RO7198574	HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB	Injection	Biological Products	Supplementary Application	2020-11-26	F.Hoffmann-La Roche Ltd	F Hoffmann-La Roche Ltd(Switzerland)	In Review	2020-11-25	view
JXSB2000039	RO7198574	HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB	Injection	Biological Products	Supplementary Application	2020-11-26	F.Hoffmann-La Roche Ltd	F Hoffmann-La Roche Ltd(Switzerland)	In Review	2020-11-25	view